Spyre Therapeutics Inc. Capital Reinvestment Ratio

Latest as of June 2021: 0.01x

Spyre Therapeutics Inc. capital reinvestment ratio. Spyre Therapeutics Inc. (SYRE) has a Capital Reinvestment Ratio of 0.01x as of June 2021, meaning it reinvests 0% of its operating cash flow ($2.08 Million) in capital expenditures ($30.00K). Check Spyre Therapeutics Inc. (SYRE) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$2.08 Million

USD

Capital Expenditures

$30.00K

USD

Data as of

Jun 2021

Most recent filing

Spyre Therapeutics Inc. Capital Reinvestment Ratio by Year (None–None)

Spyre Therapeutics Inc. capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Spyre Therapeutics Inc. cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow